| |
|
|
| |
|
|
| |
HUM-MOLGEN
-> Events
-> Meetings and Conferences |
|
|
| |
| |
| |
February 17, 2022 |
|
|
| |
|
|
| |
|
|
|
xtalks.com, webinar
Wednesday, March 09, 2022 | 11am EST (NA) / 4pm GMT (UK) / 5pm CET (EU-Central)
Who Should Attend?Executives, directors, scientists and managers from pharma, biotech and contract research organizations (CROs) responsible for the clinical development of hybrid or decentralized clinical trial solutions, in rare disease studies, including: - Research and Development
- Clinical Operations
- Clinical Science
- Outcomes Research
- Outsourcing and Procurement
- Project Management
- Clinical Trial Planning and Optimization
- Medical Affairs
What You Will LearnRegister for this webinar to learn about the: - Types of assessments that are feasible to conduct remotely in rare disease clinical trials
- Strategies for conducting remote clinical assessments
- Strategies for utilizing central raters for scoring of clinical assessments
|
|
|
|
|
|
|
|
Organized by:
|
|
xtalks.com |
|
|
Invited Speakers:
|
|
SpeakerPam Ventola, PhD, Senior Science Director, Pediatric and Rare Diseases, CogstateDr. Pam Ventola leads Cogstate’s Rare Disease and Pediatric Center for Excellence, providing strategic oversight and expert guidance throughout all stages of study planning and execution. She is also an Associate Professor at the Yale Child Study Center. As a licensed clinical psychologist, Dr. Ventola’s primary clinical expertise is in pediatric neuropsychology and specifically developmental and genetic disorders |
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
na
|
|
|
|
|
|
|
|
Registration:
|
|
https://xtalks.com/webinars/leveraging-remote-assessments-and-central-raters-to-optimize-rare-disease-clinical-trials/
|
|
|
E-mail:
|
|
shunte@xtalks.com
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp,
Frank S.
Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved.
Liability, Copyright and Imprint. |
|
